January 05, 2018
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
Thursday, January 16, 2020
University of Maryland School of Medicine Research Shows That Older Patients With Untreated Sleep Apnea Need Greater Medical Care
Obstructive sleep apnea (OSA) is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death. Researchers at the University of Maryland School of Medicine (UMSOM) found that the medical costs are substantially higher among older adults who go untreated for the disorder.
Wednesday, November 20, 2019
Dr. Eric Weintraub Recognized as "Community Star" in Conjunction with National Rural Health Day 2019 for His Opioid Disorder Treatment Work
Eric Weintraub, MD, Associate Professor of Psychiatry at the University of Maryland School of Medicine and Head of the Division of Alcohol & Drug Abuse, was named “Community Star” by the National Organization of State Offices of Rural Health
Wednesday, October 16, 2019
Researchers Discover Potential Therapy to Treat Detrimental Effects of Marijuana in Pre-Adolescent Individuals Exposed to THC in Womb
As a growing number of U.S. states legalize the medicinal and recreational use of marijuana, an increasing number of American women are using cannabis before becoming pregnant and during early pregnancy often to treat morning sickness, anxiety, and lower back pain. Although emerging evidence indicates that this may have long-term consequences for their babies’ brain development, how this occurs remains unclear.
Thursday, May 16, 2019
Dr. Christopher Welsh (SOM, UMMC) and Dr. Michelle Gourdine (UMMS) have been appointed to an opioid addiction working group by Baltimore County Executive Johnny Olszewski.
Expert working group will lead public engagement effort to gather input and develop recommendations
Thursday, April 04, 2019
Health and addiction treatment officials from the Caroline County Health Department, Maryland Department of Health, the Maryland Opioid Operational Command Center, and the University of Maryland School of Medicine (UMSOM) in Denton, MD., launched the Eastern Shore Mobile Care Collaborative (ESMCC), a mobile system designed to provide state-of-the-art treatment for opioid disorders for those in need on the Maryland Eastern shore.
Wednesday, March 27, 2019
UMSOM Researchers Discover a Critical Receptor Involved in the Response to Fast-Acting Antidepressants Like Ketamine
Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered a crucial receptor called mGlu2 that is critical to the mechanism of fast-acting antidepressants such as ketamine when used to treat depression.
Wednesday, January 23, 2019
Addiction experts at the University of Maryland School of Medicine (UMSOM) received a $212,171 grant from CareFirst to expand access to medication assisted treatment (MAT) for opioid addiction via telemedicine to patients located on Maryland’s eastern shore.
Tuesday, October 16, 2018
Bankole Johnson, DSc, MD, the Dr. Irving J. Taylor Professor and Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been named to receive the American Society of Addiction Medicine’s (ASAM) R. Brinkley Smithers Distinguished Scientist Award.
Wednesday, June 07, 2017
Dr. Jill RachBeisel Named Vice Chair for Clinical Affairs in UM School of Medicine’s Department of Psychiatry
Bankole A. Johnson, DSc, MD, MBChB, The Dr. Irving J. Taylor Professor and Chair for the Department of Psychiatry, Professor of Pharmacology, Anatomy and Neurobiology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been named Vice Chair for Clinical Affairs for the UM SOM Department of Psychiatry, commencing at the start of the next academic year.
Friday, January 09, 2015
Maryland Psychiatric Research Center at the University of Maryland School of Medicine to Participate in $11 Million International Grant to Develop New Tools for Diagnosing and Treating Brain Disorders
The Maryland Psychiatric Research Center (MPRC) will take part in the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) study, a worldwide study to developing new analytical tools to better understand mental disorders.